Incidence of major adverse kidney events after ICU admission in COVID-19 and non-COVID-19 ARDS patients
Non-COVID-19 ARDS patients face a greater risk of MAKE-365 and adverse kidney outcomes due to higher RRT requirements and mortality rates. These findings underscore the importance of tailored interventions and long-term nephrology follow-up, particularly for patients with reduced eGFR, elevated bilirubin and comorbidities like diabetes and hypoalbuminaemia.
Authors
- Jaimin Patel (ORCID: https://orcid.org/0000-0003-4120-3923)
- Faraj K. Alenezi (ORCID: https://orcid.org/0000-0001-8596-1983)
- David Thickett (ORCID: https://orcid.org/0000-0002-5456-6080)
- Rahul Y. Mahida (ORCID: https://orcid.org/0000-0003-1100-8684)
- Dhruv Parekh (ORCID: https://orcid.org/0000-0002-1508-8362)
- Mansoor N. Bangash (ORCID: https://orcid.org/0000-0001-5039-5184)
Institutions
- University Hospitals Birmingham NHS Foundation Trust (GB)
- King Saud bin Abdulaziz University for Health Sciences (SA)
- King Abdullah International Medical Research Center (SA)
- University of Birmingham (GB)
Publication Details
- Journal
- BMJ Open
- Published
- 2025-05-01
- DOI
- https://doi.org/10.1136/bmjopen-2024-094887
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00